Alvogen
Alvogen is an American pharmaceuticals company founded in 2009. In 2014, a controlling stake in the company was acquired by CVC Capital Partners and Temasek Holdings. Alvogen has about 350 different medical and non-medical products, and both produces its own products and markets the products of brand name pharmaceutical companies.
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name | Drug Name | Approved | Patent Expires | Indication |
|---|---|---|---|---|
| Acetylcysteine | Acetylcysteine | 2012-06-21 | 2025-2032 | |
| Bonsity | Teriparatide | 2019-10-04 | 2025 | |
| Bosentan | Bosentan | 2019-04-26 | 2026-2027 | |
| Buprenorphine | Buprenorphine | 2022-05-17 | 2024-2038 | |
| Buprenorphine naloxone | Buprenorphine, Naloxone | 2019-01-24 | 2024-2038 | |
| Butalbital acetaminophen | Acetaminophen, Butalbital | 2015-10-30 | 2025-2039 | |
| Butalbital, acetaminophen caffeine | Acetaminophen, Butalbital, Caffeine | 2017-01-10 | 2025-2039 | |
| Carbidopa | Carbidopa | 2016-01-08 | 2028-2039 | |
| Ciclopirox | Ciclopirox | 1997-07-21 | ||
| Dapsone | Dapsone | 2016-01-07 | 2033 | |
| Dexamethasone | Dexamethasone | 1983-04-28 | 2023-2039 | |
| Dextroamp saccharate, amp aspartate, dextroamp amp | Amphetamine, Amphetamine aspartate, Dextroamphetamine, Dextroamphetamine saccharate | 2017-07-28 | 2024-2038 |
1
2
3
4
>
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Indication |
|---|---|---|---|---|---|
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use